0001104659-18-030300.txt : 20180503
0001104659-18-030300.hdr.sgml : 20180503
20180503164301
ACCESSION NUMBER: 0001104659-18-030300
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180331
FILED AS OF DATE: 20180503
DATE AS OF CHANGE: 20180503
EFFECTIVENESS DATE: 20180503
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 18804487
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
03-31-2018
03-31-2018
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
415-801-8100
/s/ Robin L. Praeger
San Francisco
CA
05-03-2018
0
8
312675957
false
INFORMATION TABLE
2
a18-12760_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
5377944
101855
SH
OTR
0
101855
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
13621327
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
16590918
1281152
SH
OTR
0
1281152
0
Second Sight Medical Products, Inc.
Common Stock
81362J100
8626512
4492975
SH
OTR
0
4492975
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
14422150
2215384
SH
OTR
0
2215384
0
Audentes Therapeutics, Inc.
Common Stock
05070R104
36198681
1204615
SH
OTR
0
1204615
0
ImmuneDesign Corp.
Common Stock
45252L103
7287093
2208210
SH
OTR
0
2208210
0
CRISPR Therapeutics AG
Common Stock
H17182108
210551322
4606242
SH
OTR
0
4606242
0